{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "North Huntingdon",
      "address_1": "2021 Clay Pike",
      "reason_for_recall": "Marketed Without An Approved NDA/ANDA: presence of undeclared Sibutramine and Phenolphthalein.",
      "address_2": "Suite 1",
      "product_quantity": "25 boxes",
      "code_info": "all lots",
      "center_classification_date": "20151117",
      "distribution_pattern": "Nationwide",
      "state": "PA",
      "product_description": "LiDa DAIDAIHUA (also packaged as LiDa DAIDAIHUAJIAONANG), capsules, packaged in 1.6oz box 30 capsules per box, Kunming Dali Industry & Trade Co., Ltd",
      "report_date": "20151125",
      "classification": "Class I",
      "openfda": {},
      "recalling_firm": "Blue Square Market, Inc.",
      "recall_number": "D-0296-2016",
      "initial_firm_notification": "Press Release",
      "product_type": "Drugs",
      "event_id": "71912",
      "termination_date": "20181018",
      "recall_initiation_date": "20150806",
      "postal_code": "15642-6319",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}